European Archives - Page 220 of 1270 - European Medical Journal

4D Brain Map Uncovers Early Signs of Multiple Sclerosis

New 4D brain map unveils early warning signs and potential therapeutic targets for multiple sclerosis, offering hope for improved treatments.

Study Shows Positive Long-Term Safety of CAR-T Cell Therapy in B Cell Lymphoma

CAR T-cell therapy for B-cell lymphoma shows a positive long-term safety profile with few late complications.

Lifestyle and Environment Have Greater Impact on Health Than Genetics

Environmental and lifestyle factors have a significantly greater influence on health and premature death than genetics according to recent UK study.

Exploring Sword Bean Pods for Allergic Rhinitis Relief

Fine dust, a notable seasonal allergen, exacerbates allergic rhinitis symptoms and contributes to respiratory diseases.

Pomegranate Peel Extract Shows Promise in Treating NAFLD

A clinical trial found that pomegranate peel extract improves liver enzymes, triglycerides, and inflammation markers in NAFLD patients.

Handshake on a green background

Jazz Pharmaceuticals to acquire Chimerix in $935m deal

In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing oncology therapies.

Study Debunks Cardiovascular Risk Concerns with Niacinamide

Study finds no increased risk of major cardiovascular events with nicotinamide use but highlights risks for prior MACE patients.

New Model Accurately Predicts Arthritis Risk Using Common Health Indicators

A new predictive model accurately assesses arthritis risk using common health indicators, offering potential for early prevention.

Fresh Embryo Transfer Yields Higher Birth Rates for Low Prognosis IVF Patients

A large multicentre study has found that fresh embryo transfer results in higher live birth rates than frozen transfer for women with low prognosis undergoing IVF.

Personalised Cancer Vaccine Shows Promising Results in High-Risk Kidney Cancer Trial

Personalised cancer vaccines show promise in preventing recurrence of high-risk kidney cancer, targeting key driver mutations.